These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12611742)

  • 1. Drug development and Alzheimer disease.
    Roses AD; Pangalos MN
    Am J Geriatr Psychiatry; 2003; 11(2):123-30. PubMed ID: 12611742
    [No Abstract]   [Full Text] [Related]  

  • 2. Does statin use decrease the amount of Alzheimer disease pathology in the brain?
    Silbert LC
    Neurology; 2007 Aug; 69(9):E8-11. PubMed ID: 17724280
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease.
    Henley DB; May PC; Dean RA; Siemers ER
    Expert Opin Pharmacother; 2009 Jul; 10(10):1657-64. PubMed ID: 19527190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Siegel GJ; Chauhan NB; Feinstein DL; Li G; Larson EB; Breitner JC; Montine TJ
    Neurology; 2008 Jul; 71(5):383; author reply 383. PubMed ID: 18663190
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Hussain HM; Zakria M; Arshad AR
    Neurology; 2008 Dec; 71(24):2019; author reply 2019-20. PubMed ID: 19064888
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Pappolla MA
    Neurology; 2008 Dec; 71(24):2020; author reply 2020-1. PubMed ID: 19086266
    [No Abstract]   [Full Text] [Related]  

  • 7. Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy.
    Skolnick AA
    JAMA; 1997 Mar; 277(10):776. PubMed ID: 9052690
    [No Abstract]   [Full Text] [Related]  

  • 8. Saving the mind faces high hurdles.
    Travis J
    Science; 2005 Jul; 309(5735):731. PubMed ID: 16051787
    [No Abstract]   [Full Text] [Related]  

  • 9. [Memory mechanisms and expectancy of therapy in Alzheimer's disease].
    Vetulani J
    Neurol Neurochir Pol; 2000; 34(3):429-46. PubMed ID: 10979538
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Golomb BA; Evans MA
    Neurology; 2008 Jun; 70(24):2349; author reply 2349-50. PubMed ID: 18541892
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease: will advances made in the past turn the tide?
    Semla TP
    Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
    [No Abstract]   [Full Text] [Related]  

  • 12. A promising new treatment for Alzheimer's disease?
    O'Brien JT
    Lancet Neurol; 2008 Sep; 7(9):768-9. PubMed ID: 18702997
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the pharmacotherapy of Alzheimer's disease.
    Gauthier S
    CMAJ; 2002 Mar; 166(5):616-23. PubMed ID: 11898943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Li G; Larson EB; Sonnen JA; Shofer JB; Petrie EC; Schantz A; Peskind ER; Raskind MA; Breitner JC; Montine TJ
    Neurology; 2007 Aug; 69(9):878-85. PubMed ID: 17724290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
    Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E
    Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: unraveling the tangle.
    Bonney RC
    Am Clin Lab; 1998; 17(1):4. PubMed ID: 10177661
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
    Silva T; Teixeira J; Remião F; Borges F
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of Alzheimer disease: new drugs and novel strategies.
    Giacobini E
    Prog Brain Res; 1993; 98():447-54. PubMed ID: 8248535
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of clinical trials for Alzheimer-type dementia in Japan: strategies to facilitate the development of antidementia drugs.
    Homma A
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S123-6. PubMed ID: 10850741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.